Steven Swift to Treatment Outcome
This is a "connection" page, showing publications Steven Swift has written about Treatment Outcome.
Connection Strength
0.450
-
Treatment outcomes of overactive bladder with combined therapies of botulinum toxin injections and oral agents. Int Urogynecol J. 2021 Oct; 32(10):2803-2806.
Score: 0.082
-
Factors affecting patient choice for continued observation versus intervention for pelvic organ prolapse. Int Urogynecol J. 2021 02; 32(2):273-278.
Score: 0.078
-
The use of vaginal mesh has no advantage over conventional surgery in the treatment of prolapse: FOR: The case of mistaken doctor bias. BJOG. 2016 Jan; 123(1):143.
Score: 0.057
-
Intrinsic sphincter deficiency: what is it and does it matter anymore? Int Urogynecol J. 2013 Feb; 24(2):183-4.
Score: 0.046
-
Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse. Neurourol Urodyn. 2013 Apr; 32(4):383-6.
Score: 0.045
-
To mesh or not to mesh? That is the question. Int Urogynecol J. 2011 May; 22(5):505-6.
Score: 0.041
-
Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-label, flexible-dosing, multicentre study. Clin Drug Investig. 2009; 29(5):305-16.
Score: 0.035
-
Solifenacin is effective for the treatment of OAB dry patients: a pooled analysis. Eur Urol. 2005 Sep; 48(3):483-7.
Score: 0.028
-
Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial. Eur J Obstet Gynecol Reprod Biol. 2016 Jan; 196:6-10.
Score: 0.014
-
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for reporting outcomes of surgical procedures for pelvic organ prolapse. Neurourol Urodyn. 2012 Apr; 31(4):415-21.
Score: 0.011
-
Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial. BJU Int. 2010 Jan; 105(1):58-66.
Score: 0.009
-
Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: a multicenter, placebo-controlled trial. Am J Obstet Gynecol. 1995 Jul; 173(1):72-9.
Score: 0.003